# Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash

> **NCT01256437** · PHASE2 · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 90 (actual)

## Conditions studied

- Acneiform Rash

## Interventions

- **DRUG:** Threolone ointment
- **DRUG:** ointment Synthomycine
- **DRUG:** Aqua cream

## Key facts

- **NCT ID:** NCT01256437
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-03
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256437, "Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01256437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*